Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis ... Read More
-
Positive Material Identification
... at a CAGR of 6.5% over the analysis period 2024-2030. Positive Material Identification Equipment, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.2 Billion by the ... Read More
-
Surgical Imaging Technologies
... at a CAGR of 2.7% over the analysis period 2024-2030. Image Intensifier C-arms Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$3.4 Billion by the ... Read More
-
Radiosurgery and Radiotherapy Robots
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. X-Ray Based Robots, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.2 Billion by ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Western Blotting Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
X-Ray Tubes
... CAGR of 3.9% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.0 Billion by the end of the analysis ... Read More
-
Microbiology Culture
... CAGR of 3.8% over the analysis period 2024-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of the analysis ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Flat Panel X-Ray Detectors
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Manufacturing Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$741.3 Million by the ... Read More
-
Medical Device Market Medical Device Market by Device Type, Function, Durability, Therapeutic Segment, Risk Classification, Manufacture Method, Delivery/Acquisition, Operational Support Model, Connectivity and Region 2025 – 2030
... (hospital, home, clinic, etc.), function (critical care, diagnostic, dental, etc.), durability, risk classification, manufacturing method (traditional vs. 3D printed), delivery/acquisition method, operational support model, and connectivity (Bluetooth, cellular, Wi-Fi, etc.). It also examines the therapeutic ... Read More
-
Brain Tumor Diagnosis and Treatment
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Radioactive Materials Logistics
... at a CAGR of 4.1% over the analysis period 2024-2030. Fresh Fuel Radioactive Materials, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$3.0 Billion by the ... Read More
-
Fetal Monitoring
... CAGR of 6.1% over the analysis period 2024-2030. Ultrasound Systems, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Ancestry & Relationship Testing, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.3 Billion ... Read More
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and ... Read More
-
Computed Tomography (CT) Scanners
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. High-End Slice Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by ... Read More
-
Scintillators
... 4.9% over the analysis period 2024-2030. Inorganic Scintillators, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$492.3 Million by the end of the analysis period. Growth ... Read More
-
Image Guided Surgery Devices
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.4 Million by the end ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Medical Imaging Equipment Services
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Equipment Repair & Maintenance Services, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$17.9 ... Read More
-
Single Photon Emission Computed Tomography (SPECT)
... reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Standalone SPECT, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
Research Assistance
